Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지
DOI QR코드

DOI QR Code

Korean National Health Insurance Value Incentive Program: Achievements and Future Directions

  • Kim, Sun-Min (Health Insurance Review and Assessment Service) ;
  • Jang, Won-Mo (Health Insurance Review and Assessment Service) ;
  • Ahn, Hyun-Ah (Health Insurance Review and Assessment Service) ;
  • Jeong, Hyang (Health Insurance Review and Assessment Service) ;
  • Ahn, Hye-Sook (Health Insurance Review and Assessment Service)
  • Received : 2012.02.14
  • Accepted : 2012.05.15
  • Published : 2012.05.31
Download PDF
⟨ Previous Next ⟩

Abstract

Since the reformation of the National Health Insurance Act in 2000, the Health Insurance Review and Assessment Service (HIRA) in the Republic of Korea has performed quality assessments for healthcare providers. The HIRA Value Incentive Program (VIP), established in July 2007, provides incentives for excellent-quality institutions and disincentives for poorquality ones. The program is implemented based on data collected between July 2007 and December 2009. The goal of the VIP is to improve the overall quality of care and decrease the quality gaps among healthcare institutions. Thus far, the VIP has targeted acute myocardial infarction (AMI) and Caesarian section (C-section) care. The incentives and disincentives awarded to the hospitals by their composite quality scores of the AMI and C-section scores. The results of the VIP showed continuous and marked improvement in the composite quality scores of the AMI and C-section measures between 2007 and 2010. With the demonstrated success of the VIP project, the Ministry of Health and Welfare expanded the program in 2011 to include general hospitals. The HIRA VIP was deemed applicable to the Korean healthcare system, but before it can be expanded further, the program must overcome several major concerns, as follows: inclusion of resource use measures, rigorous evaluation of impact, application of the VIP to the changing payment system, and expansion of the VIP to primary care clinics.

Keywords

References

  1. Health Insurance Review and Assessment Service. Comprehensive quality report of National Health Insurance 2009. Seoul: Health Insurance Review and Assessment Service; 2010, p. 3-38, 60-68, 105-117 (Korean).
  2. Health Insurance Review and Assessment Service. Comprehensive quality report of National Health Insurance 2010. Seoul: Health Insurance Review and Assessment Service; 2011, p. 3-43, 66-73, 127-141 (Korean).
  3. Organisation for Economic Cooperation and Development. Health at a glance 2011: OECD indicators, OECD publishing. Paris: Organisation for Economic Co-operation and Development; 2011, p. 96-97.
  4. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol 2004;44(3):E1-E211.
  5. Spertus JA, Radford MJ, Every NR, Ellerbeck EF, Peterson ED, Krumholz HM, et al. Challenges and opportunities in quantifying the quality of care for acute myocardial infarction: summary from the Acute Myocardial Infarction Working Group of the American Heart Association/ American College of Cardiology First Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke. Circulation 2003;107(12):1681-1691.
  6. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361(9351):13-20.
  7. Boersma E, Pieper KS, Steyerberg EW, Wilcox RG, Chang WC, Lee KL, et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation 2000;101(22):2557-2567.
  8. Marciniak TA, Ellerbeck EF, Radford MJ, Kresowik TF, Gold JA, Krumholz HM, et al. Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. JAMA 1998;279(17):1351-1357.
  9. Baigent C, Collins R, Appleby P, Parish S, Sleight P, Peto R. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. BMJ 1998;316(7141):1337-1343.
  10. Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ 1994;308(6921):81-106.
  11. Park JS, Kang CH, Kim CY. Can cesarean section rate be used as a hospital-wide quality indicator in Korean hospitals? Korean J Obstet Gynecol 1997;40(9):1943-1953 (Korean).
  12. Librero J, Peiro S, Calderon SM. Inter-hospital variations in caesarean sections. A risk adjusted comparison in the Valencia public hospitals. J Epidemiol Community Health 2000;54(8):631-636.
  13. Joint Commission on Accreditation of Healthcare Organizations. Framework for improving performance: a guide for nurse. Oakbrook Terrace: Joint Commission on Accreditation of Healthcare Organizations; 1994, p. 205.
  14. Mann LI, Gallant J. Modern indications for cesarean section. Am J Obstet Gynecol 1979;135(4):437-441.
  15. Lee SI, Khang YH, Ha BM, Lee MS, Kang W, Koo HJ, et al. Inter-hospital comparison of cesarean section rates after risk adjustment. Korean J Prev Med 2001;34(4):337-346 (Korean).
  16. Lee KS, Lee SI, Seo K, Do YM. Impact of risk adjustment with insurance claims data on cesarean delivery rates of healthcare organizations in Korea. J Prev Med Public Health 2005;38(2):132-140 (Korean).

Cited by

  1. 성과연동지불제도의 확대 가능성 고찰 vol.23, pp.1, 2012, https://doi.org/10.4332/kjhpa.2013.23.1.003
  2. Impact of health insurance status changes on healthcare utilisation patterns: a longitudinal cohort study in South Korea vol.6, pp.4, 2012, https://doi.org/10.1136/bmjopen-2015-009538
  3. Changes in Saturday outpatient volume and billings after introducing the Saturday incentive programme to clinics in South Korea: a longitudinal cohort study using claims data from 2012 to 2014 vol.6, pp.6, 2016, https://doi.org/10.1136/bmjopen-2016-011248
  4. Association between human resources and risk of hospitalisation in end-stage renal disease outpatients receiving haemodialysis: a longitudinal cohort study using claim data during 2013–2014 vol.6, pp.8, 2012, https://doi.org/10.1136/bmjopen-2016-011319
  5. Association Between Results of Quality Assessment of Long‐Term Care Facilities and Hospital‐Acquired Pneumonia in Individuals with Stroke or Neurodegenerative Disease in Korea vol.64, pp.12, 2016, https://doi.org/10.1111/jgs.14536
  6. Caesarean Section Rates and Activity-Based Funding in Northern Norway: A Model-Based Study Using the World Health Organization's Recommendation vol.2018, pp.None, 2012, https://doi.org/10.1155/2018/6764258
  7. Designing a Framework for “Iranian Pay for Performance” Program for Non-Medical Workforce in Hospitals vol.7, pp.0, 2012, https://doi.org/10.5812/jhealthscope.65472
  8. Design and effects of outcome-based payment models in healthcare: a systematic review vol.20, pp.2, 2019, https://doi.org/10.1007/s10198-018-0989-8
  9. Accuracy of an administrative database for pancreatic cancer by international classification of disease 10th codes: A retrospective large-cohort study vol.25, pp.37, 2012, https://doi.org/10.3748/wjg.v25.i37.5619
  10. Dilemmas Within the Korean Health Insurance System vol.53, pp.4, 2020, https://doi.org/10.3961/jpmph.20.074
  11. Performance Pay in Hospitals: An Experiment on Bonus–Malus Incentives vol.17, pp.22, 2012, https://doi.org/10.3390/ijerph17228320